JDD Highlights

Congratulations to Our Holiday Giveaway Winner

By December 13, 2019April 12th, 2023No Comments
Congratulations, Sherna!
Introducing our 2019 Holiday Giveaway Winner
Thank you to all who participated in our 2019 Instagram Holiday Giveaway Contest! Here’s our lucky winner!

Sherna from Ontario, Canada. Sherna is a Medical Representative for Uriage in Ontario.

 

“In my spare time, I like to be out in the city of Toronto, where I live.  It’s an amazing place to eat, drink and visit with friends.”

“What I like about JDD is that it is a fantastic resource for people like myself, who are not health care providers (but work with them) and want to keep up with the current clinical data and trends.  I’m gifting myself a subscription for Christmas!”

You May Also Like

Journal of Drugs in Dermatology JDD Article about The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United StatesDerm CommunityFeatured ArticlesLatest NewsSkin of Color
December 10, 2025

The Overlooked Burden: Psychodermatologic Needs of Hispanic and Latinx Communities in the United States

Review highlights higher psychiatric comorbidity, systemic barriers to care, and the value of integrated psychodermatologic models This article in the December 2025 issue of JDD discusses how Hispanic and Latinx…
Journal of Drugs in Dermatology JDD Author Spotlight featuring Natalia N. Khosla MD.AlopeciaAuthor SpotlightDerm CommunityFeatured ArticlesLatest NewsThe Latest
July 22, 2025

July Author Spotlight

Author Spotlight: Dr. Natalia Neha Khosla on Health Equity, Inflammation, and Innovation in Dermatology July’s JDD Author Spotlight  features Natalia Neha Khosla, MD MSc, author of the July article, “Socioeconomic…
AcneDerm CommunityFeatured ArticlesJDD HighlightsJDD in the MediaThe Latest
May 21, 2025

JDD in the News: Upadacitinib’s Potential Cardiovascular Effects 

Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…